- Home
- XFOR vs USCB Comparison
XFOR vs USCB Comparison
Compare XFOR & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XFOR | USCB |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 323.5M | 352.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | XFOR | USCB |
|---|---|---|
| Price | $3.56 | $19.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $28.50 | $22.00 |
| AVG Volume (30 Days) | ★ 420.2K | 54.5K |
| Earning Date | 03-24-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | N/A | ★ 7.26 |
| EPS | N/A | ★ 1.33 |
| Revenue | $33,979,000.00 | ★ $87,925,000.00 |
| Revenue This Year | $1,266.01 | $26.48 |
| Revenue Next Year | N/A | $9.76 |
| P/E Ratio | ★ N/A | $15.14 |
| Revenue Growth | ★ 2925.74 | 10.57 |
| 52 Week Low | $1.35 | $15.39 |
| 52 Week High | $17.96 | $20.79 |
Technical Indicators
Market Signals| Indicator | XFOR | USCB |
|---|---|---|
| Relative Strength Index (RSI) | 41.78 | 56.79 |
| Support Level | $3.52 | $19.70 |
| Resistance Level | $3.74 | $20.52 |
| Average True Range (ATR) | 0.18 | 0.86 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 7.56 | 71.45 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.